Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Pediatr Diabetes. 2011 May;12(3 Pt 1):150–155. doi: 10.1111/j.1399-5448.2010.00674.x

Figure 1.

Figure 1

Cellular Immunoblotting Responses in subjects enrolled in DPT-1 parenteral insulin trial. (a) Control arm subjects, n=7 (b) Treatment arm subjects, n=10.

Subjects with more than 3 immunoblot sections are considered to have a positive cellular assay response. Circles indicate date of diagnosis of type 1 diabetes in 5 subjects.